Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
Clinical trial NCT01334086 · COMPLETED
Trial details
- NCT number
- NCT01334086
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-08-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.